Analysis: Restricting Medicare Part D Generics to Generic Coverage Tiers Could Save Patients Billions

Drug Industry Daily
A proposed Centers for Medicare & Medicaid Services requirement that Medicare Part D plans place generics only on generic formulary tiers could have lowered patients’ drug costs by almost $16 billion over a three-year period, according to an analysis by healthcare consulting firm Avalere.

To View This Article:


Subscribe To Drug Industry Daily